Cargando…
Combination of highly antigenic nucleoproteins to inaugurate a cross-reactive next generation vaccine candidate against Arenaviridae family
Arenaviral infections often result lethal hemorrhagic fevers, affecting primarily in African and South American regions. To date, there is no FDA-approved licensed vaccine against arenaviruses and treatments have been limited to supportive therapy. Hence, the study was employed to design a highly im...
Autores principales: | Azim, Kazi Faizul, Lasker, Tahera, Akter, Rahima, Hia, Mantasha Mahmud, Bhuiyan, Omar Faruk, Hasan, Mahmudul, Hossain, Md Nazmul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144012/ https://www.ncbi.nlm.nih.gov/pubmed/34041391 http://dx.doi.org/10.1016/j.heliyon.2021.e07022 |
Ejemplares similares
-
Inhibition of Arenaviridae nucleoprotein exonuclease by bisphosphonate
por: Nguyen, Thi Hong Van, et al.
Publicado: (2022) -
Brothers in Arms: Structure, Assembly and Function of Arenaviridae Nucleoprotein
por: Papageorgiou, Nicolas, et al.
Publicado: (2020) -
Human Pathogenic Arenaviruses (Arenaviridae)
por: Radoshitzky, Sheli R., et al.
Publicado: (2019) -
Transcription and replication mechanisms of Bunyaviridae and Arenaviridae L proteins
por: Ferron, François, et al.
Publicado: (2017) -
Proteome Exploration of Legionella pneumophila To Identify Novel Therapeutics: a Hierarchical Subtractive Genomics and Reverse Vaccinology Approach
por: Khan, Md Tahsin, et al.
Publicado: (2022)